APPLICATIONS PUBLISHED 24 MARCH 2004
Published: 1-Sep-2004
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492
Oral compsns and use thereof
University of Rochester; Universidade Estudual de Campinas 1399119*
Breath protection microcapsules
Warner-Lambert 1399120*
Olopatadine formulations for topical administration
Alcon 1399127*
Compsns with controlled release of lactic acid at vaginal level
Università Degli Studi Di Pavia 1399128*
Emulsion and dispersion formulations and methods
Jupitar 1399130*
Spray freeze-dried compsns
Powderject Vaccines 1399131*
Production of hard, dense particles
Powderject Vaccines 1399132*
Sustained-release compsn comprising lactic acid-glycolic acid copolymer and process for producing the same
Takeda Chemical Industries 1399133*
Differential delivery of nitric oxide
Boston Scientific 1399134*
Methods for hermetically sealing microchip reservoir devices
Microchips 1399135*
Process for the preparation of dispersions
Roche Vitamins 1399136*
Sulphonamides
SmithKline Beecham 1399137*
Method for the production of solid formulations of sodium 3-hydroxy-3-methylbutyrate
Lonza 1399138*
Compsns based on branched chain amino acids for improving the myocardial ventricular function in patients suffering from diabetes
Professional Dietetics 1399139*
Biological response modifier compsn and uses thereof
Lorus Therapeutics 1399140*
Use of acetyl L-carnitine for the preparation of a medication for the preventive therapy for pain
Sigma-Tau Industrie Farmaceutiche Riunite 1399141*
Use of acetyl L-carnitine in association with the biotin for the treatment of patients with type 2 insulin resistant diabetes mellitus
Sigma-Tau Industrie Farmaceutiche Riunite 1399142*
Use of an alkanoyl L-carnitine for the preparation of a medication to treat anhedonia
Sigma-Tau Industrie Farmaceutiche Riunite 1399143*
Carbamate compounds for use in preventing or treating anxiety disorders
Ortho-McNeil Pharmaceuticals 1399144*
Pressure sensitive adhesive matrix patch for the treatment of onchomycosis
Watson Pharmaceuticals 1399145*
Novel compounds and compsns as cathepsin inhibitors
Axys Pharmaceuticals 1399146*
Therapeutic delivery of carbon monoxide
Northwick Park Institute for Medical Research 1399147*
Multifunctional carbonates and derivatives
Huntsman Petrochemical 1399148*
Taxane prodrugs
Nobex Corp 1399149*
Vitamin C compsns
Oxycal Laboratories 1399150*
A method for treating inflammatory diseases by administering a PPAR-delta agonist
Merck 1399151*
Pharmaceutical compsn comprising a lipase inhibitor and a sucrose fatty acid ester
F Hoffmann-La Roche 1399152*
Pharmaceutical compsn comprising a drug and a fatty acid or salt thereof
F Hoffmann-La Roche 1399153*
3-fluoro-pyrroidines as antidiabetic agents
Ferring 1399154*
Small molecules useful in the treatment of inflammatory disease
Boehringer Ingelheim Pharmaceuticals 1399155*
Alkylidine pirazolidinedione derivatives and their use in treating diabetes and obesity
Applied Research Systems 1399156*
Compsn comprising a P-GP inhibitor and an anti-epileptic drug
Novartis 1399157*
Aromatase inhibitors as novel veterinary drugs
Vetcare Oy 1399158*
4-substituted-1-(arylmethylidene)-thiosemicarbazide, 4-substituted-1-(arylcarbonyl)thiosemicarbazide and analogues as activators of caspases and inducers or apoptosis and the use thereof
Cytovia 1399159*
NR2B receptor antagonists for the treatment and prevention of migraines
Merck 1399160*
Sustained-release analgesic compounds
Control Delivery Systems 1399161*
Treating neuropathic/inflammatory pain by targeting a compsn (e.g. ZD7288) to HCN pacemaker channels
Ortho-McNeil Pharmaceuticals; The Regents of the University of California San Diego 1399162*
Compounds methods and compsns useful for the treatment of bovine viral diarrhoea virus (BVDV) infection and hepatitis C virus (HCV) infection
University of North Carolina at Chapel Hill; Georgia State University Research Foundation; Auburn University 1399163*
Antimycotic agent
BASF 1399164*
Stabilised dispersion of phytosterol in oil
Novartis Nutrition 1399165*
A pharmaceutical combination comprising either (S)-2-ethoxy-3-4-(2-4-methane sulphonyl oxyphenyl ethoxy)phenyl]propanoic acid or 3-4-2-(4-tert-butoxy carbonyl aminophenyl)ethoxy]-(S)-2-ethoxy propanoic acid and a sulphonylurea
AstraZeneca 1399166*
Arylazo-substituted imidazole for the treatment of stress urinary incontinence
Perry, Robert Edward 1399167*
Xenogenic oligo or/and polyribonucleotides as agents for the treatment of malignant tumours
IPL International Pharmaceuticals 1399168*
Exothermic formulations for the treatment of ectoparasites
Schering-Plough 1399169*
Chelates of metals which can be activated by neutrons and their use for the measurement of labelled specimens
Biophysics Assay Laboratory 1399170*
Medicinal herbal compounds for the prevention and treatment of diabetes
Holomed Pharmaceuticals 1399171*
Seal-oil-based pharmaceutical, cosmetic, dermo-cosmetic, hygiene, alimentary and para-alimentary (food-supplement) products; their method of preparation; their uses as preventive and/or as therapeutic agents
Fundaçao Esspritt-Icarus (Fundaçao Europeia de Investigaçao Medica) 1399172*
Pharmaceutical preparation containing active ingredients extracted from the plants Centrella asiatica, Mahonia aquifolium and Viola tricolor
Weber and Weber 1399173*
Nucleic acid and corresponding protein entitled 121P1F1 useful in treatment and detection of cancer
Agensys 1399174*
Therapeutic use of rank antagonists
Immunex 1399175*
Substantially pure glycopeptide antibiotics AC-98-1; AC-98-2; AC-98-3; AC-98-4 and AC-98-5
Wyeth Holdings 1399176*
BMP binding proteins for use in bone or cartilage regeneration
Smith & Nephew 1399177*
Methods of treating metabolic disorders using neuronatin polypeptides
Azign Bioscience 1399178*
Pharmaceutical compsns which inhibit proliferation of pituitary adenomas and method of use
Societe de Conseils de Recherches et d'Applications Scientifiques 1399179*
Sulphated CCR5 peptides for HIV-1 infection
Progenics Pharmaceuticals; Aaron Diamond AIDS Research Centre 1399180*
Peptide vaccines against group A streptococci
The Government of the USA as represented by the Secretary of the Department of Health and Human Services 1399181*
Papillomavirus vaccines
Xenova Research; Leiden University Medical Centre 1399182*
Chimeric alphavirus replicon particles
Chiron Corp 1399183*
Use of mammalian genes and related reagents
Schering 1399184*
Use of polyclonal immunoglobulins as vaccine
Igeneon Krebs-Immunotherapie Forschungs-und-Entwicklungs 1399185*
Medicament for treating tumours and their metastases using a binding molecule against bone-sialo-protein
Osteopep-Pharma 1399186*
